INVX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Innovex International Inc (INVX) is not a strong buy at this time for a beginner, long-term investor with $50,000-$100,000 available. While the technical indicators show a bullish trend, the lack of significant positive catalysts, insider selling, and weak financial performance in the latest quarter suggest caution. Holding off for now would be prudent.
The technical indicators show a bullish trend with SMA_5 > SMA_20 > SMA_200 and a positive MACD histogram of 0.177. RSI is at 66.37, indicating a neutral zone. The stock is trading near the resistance level of R1: 26.713, with a pivot at 25.703.
The stock has an 80% chance of gaining 6.28% in the next month based on historical candlestick patterns. Analysts at Barclays raised the price target to $24 from $20, citing a strong Q4 report.
Insiders are heavily selling, with a 39142.42% increase in selling activity over the last month. Financial performance in Q4 2025 was weak, with net income dropping by -56.06% YoY and EPS declining by -39.39%. Gross margin also fell by -19.93%. No recent news or congress trading data is available.
In Q4 2025, revenue increased by 9.14% YoY to $273.6M. However, net income dropped significantly by -56.06% YoY to $13.97M, and EPS fell by -39.39% to 0.2. Gross margin decreased to 23.26%, down -19.93% YoY.
Barclays raised the price target to $24 from $20 and maintained an Equal Weight rating. The firm views the company's Q4 report as strong, but the price target remains below the current market price of $26.29.
